The release of the snapshot containing the respective simulations can be found here: <https://github.com/Open-Systems-Pharmacology/Probenecid-Furosemide-DDI>

The Probenecid-furosemide DDI was initially developed and published by [Britz 2020](#5-references) and adjusted later on to PK-Sim V11. This DDI was characterized by competitive inhibition of OAT3 and MRP4 and non-competitive inhibition of UGT1A9. 

The Probenecid / Furosemide interaction was evaluated using 5 clinical DDI studies including 6 different clinical settings ([Homeida 1977](#references), [Smith 1980](#references), [Wiebe 2020](#references), [Shen 2019](#references), [Vree 1995](#references)).

| DataID | Transporter | Perpetrator / victim     | Study design                                                                                                                                               | Comment | Clinical study                      |
|---:|:---|:--------|:----------------------------------------------|:---|:------|
|  17000 | OAT  | Probenecid / Furosemide | Probenecid: **500** mg PO,-, QID (D1-D3) **1000** mg PO,-, SD (D4) Furosemide: **40** mg IV (bolus), sd (D4)  |   2h dose gap      | [Homeida 1977](#references)        |
|  17001 | OAT  | Probenecid / Furosemide | Probenecid: **1000** mg PO, tablet, BID (D1) Furosemide: **40** IV (3min), SD (D1) |   1 h dose gap      | [Smith 1980](#references)        |
|    17002 | OAT  | Probenecid / Furosemide | Probenecid: **1000** mg PO, tablet, BID (D1) Furosemide: **1** mg PO, solution, SD (D1)  |   1 h dose gap       | [Wiebe 2020](#references)       |
|  17003 | OAT   | Probenecid / Furosemide | Probenecid: **400** mg PO, tablet, BID (D1) Furosemide: **40** mg PO, solution, SD (D1)|   1 h dose gap       | [Wiebe 2020](#references)        |
|  17004 | OAT   | Probenecid / Furosemide | Probenecid: **1000** mg PO, tablet, SD (D1) Furosemide: **40** mg PO, solution, SD (D1)|   1 h dose gap       | [Shen 2019](#references)        |
|  17005 | OAT   | Probenecid / Furosemide | Probenecid: **1000** mg PO, tablet, SD (D1) Furosemide: **80** mg PO single dose|    1 h dose gap      | [Vree 1995](#references)        |


**PO:** oral administration
**IV:** intravenous
**-:** formulation not mentioned
**QID:** four times daily
**BID:** twice daily
**SD:** single dose
**D:** day of administration


